Voyager Acquisition Corp. /
VERAXA
Voyager Acquisition Corp. and VERAXA enter business combination agreement




Source for the buyer and target: Voyager Acquisition Corp.
For the buyer and target.
“On April 22, 2025, VERAXA entered into a definitive business combination agreement (the “Business Combination Agreement”) with Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ: VACH, “Voyager”).”
Published 30 Sep 2025
Open the sourceWhat happened
Voyager Acquisition Corp. and VERAXA entered into a definitive business combination agreement on April 22, 2025. VERAXA is an emerging leader in designing novel cancer therapies. [01]
Upon closing, VERAXA is expected to become a publicly traded company listed on NASDAQ. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Voyager Acquisition Corp. and VERAXA enter business combination agreement
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
“Voyager Acquisition Corp. and VERAXA enter business combination agreement Voyager Acquisition Corp. and VERAXA entered into a definitive business combination agreement on April 22, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly